Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

Blood (2019) 134 (26): 2361–2368.

https://doi.org/10.1182/blood.2019001641

Published: 2019

Includes: Supplemental data

Journal Articles

Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML

Brian C. Shaffer, MD, Glenn Heller, PhD, Jean-Benoit Le Luduec, PhD, Jack Vahradian, Miguel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Boglarka Gyurkocza, MD, Ann A. Jakubowski, MD PhD, E B Papadopoulos, MD, Jeanette E Boudreau, BSc, PhD, Nancy A. Kernan, MD, Katharine C. Hsu, MD PhD

Blood (2016) 128 (22): 990.

https://doi.org/10.1182/blood.V128.22.990.990

Published: 2016

Journal Articles

Safe mobilization of CD34 + cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

Farid Boulad, Xiuyan Wang, Jinrong Qu, Clare Taylor, Leda Ferro, Garyfalia Karponi, Shirley Bartido, Patricia Giardina, Glenn Heller, Susan E. Prockop, Aurelio Maggio, Michel Sadelain, Isabelle Rivière

Blood (2014) 123 (10): 1483–1486.

https://doi.org/10.1182/blood-2013-06-507178

Published: 2014

Includes: Supplemental data

Journal Articles

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

Blood (2013) 122 (21): 546.

https://doi.org/10.1182/blood.V122.21.546.546

Published: 2013

Journal Articles

Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1

Emanuela Romano, Jesse W. Cotari, Rosa Barreira da Silva, Brian C. Betts, David J. Chung, Francesca Avogadri, Mitsu J. Fink, Erin T. St Angelo, Babak Mehrara, Glenn Heller, Christian Münz, Gregoire Altan-Bonnet, James W. Young

Blood (2012) 119 (22): 5182–5190.

https://doi.org/10.1182/blood-2011-09-382200

Published: 2012

Journal Articles

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation

Blood (2012) 119 (11): 2644–2656.

https://doi.org/10.1182/blood-2011-08-371971

Published: 2012

Includes: Supplemental data

Journal Articles

Janus Kinase-2 Inhibition Induces Durable Tolerance to Alloantigen by Dendritic Cell-Stimulated Human T Cells, Yet Preserves Immunity to Recall Antigen

Brian C. Betts, MD, Omar Abdel-Wahab, MD, Shane A Curran, PhD, Erin T St. Angelo, Priya Koppikar, Glenn Heller, PhD, Ross L Levine, MD, James W Young, MD

Blood (2011) 118 (21): 1903.

https://doi.org/10.1182/blood.V118.21.1903.1903

Published: 2011

Journal Articles

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Guenther Koehne, MD PhD, Heather Landau, MD, Hani Hassoun, MD, Alex Lesokhin, MD, Nikoletta Lendvai, MD PhD, Michael A. Rosenzweig, MD, Glenn Heller, PhD, Sergio Giralt, MD

Blood (2011) 118 (21): 1992.

https://doi.org/10.1182/blood.V118.21.1992.1992

Published: 2011

Journal Articles

Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell–stimulated T cells yet preserves immunity to recall antigen

Brian C. Betts, Omar Abdel-Wahab, Shane A. Curran, Erin T. St Angelo, Priya Koppikar, Glenn Heller, Ross L. Levine, James W. Young

Blood (2011) 118 (19): 5330–5339.

https://doi.org/10.1182/blood-2011-06-363408

Published: 2011

Includes: Supplemental data

Journal Articles

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Blood (2011) 118 (18): 4817–4828.

https://doi.org/10.1182/blood-2011-04-348540

Published: 2011

Includes: Supplemental data

Journal Articles

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL

Alan M. Hanash, Lucy W. Kappel, Nury L. Yim, Rebecca A. Nejat, Gabrielle L. Goldberg, Odette M. Smith, Uttam K. Rao, Lindsay Dykstra, Il-Kang Na, Amanda M. Holland, Jarrod A. Dudakov, Chen Liu, George F. Murphy, Warren J. Leonard, Glenn Heller, Marcel R. M. van den Brink

Blood (2011) 118 (2): 446–455.

https://doi.org/10.1182/blood-2010-07-294785

Published: 2011

Includes: Supplemental data

Journal Articles

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts

Sharon Avery, Weiji Shi, Marissa Lubin, Anne Marie Gonzales, Glenn Heller, Hugo Castro-Malaspina, Sergio Giralt, Nancy A. Kernan, Andromachi Scaradavou, Juliet N. Barker

Blood (2011) 117 (12): 3277–3285.

https://doi.org/10.1182/blood-2010-08-300491

Published: 2011

Journal Articles

Recombinant Human Interleukin-7 (CYT107) Enhances CD4 and CD8 T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant In Patients with Myeloid Malignancies

Blood (2010) 116 (21): 674.

https://doi.org/10.1182/blood.V116.21.674.674

Published: 2010

Journal Articles

Abrogation of Donor T Cell IL-21 Signaling Leads to Tissue-Specific Modulation of Immunity and Separation of Gvhd From GVL

Alan M. Hanash, MD, PhD, Lucy W. Kappel, Nury L. Yim, Rebecca A. Nejat, Gabrielle L. Goldberg, Odette M. Smith, Uttam K. Rao, Lindsay Dykstra, Il-Kang Na, Amanda M. Holland, Chen Liu, George F. Murphy, Warren J Leonard, Glenn Heller, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2010) 116 (21): 729.

https://doi.org/10.1182/blood.V116.21.729.729

Published: 2010

Journal Articles

A Novel Reduced Intensity Conditioning Can Induce a High Incidence of Sustained Donor Engraftment After Double Unit Cord Blood Transplantation (CBT) without Anti-Thymocyte Globulin

Doris M Ponce, MD, Craig Sauter, MD, Marissa Lubin, BA, Anne Marie Gonzales, BS, Glenn Heller, PhD, Hugo Castro-Malaspina, MD, Sergio Giralt, MD, Nancy A. Kernan, MD, Esperanza B. Papadopoulos, MD, Andromachi Scaradavou, MD, Juliet N. Barker, MBBS, (Hons), FRACP

Blood (2010) 116 (21): 2351.

https://doi.org/10.1182/blood.V116.21.2351.2351

Published: 2010

Journal Articles

An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment

Lamis K. Eldjerou, Sonali Chaudhury, Ada Baisre-de Leon, Mai He, Maria E. Arcila, Glenn Heller, Richard J. O'Reilly, Juliet N. Barker, Malcolm A. Moore

Blood (2010) 116 (19): 3999–4006.

https://doi.org/10.1182/blood-2010-03-276212

Published: 2010

Journal Articles

Response: Sample size and statistical comparisons of GVHD rates in pediatric Niemann-Pick disease patients

Richard Kolesnick, Marcel van den Brink, Glenn Heller, Jimmy A. Rotolo

Blood (2010) 115 (2): 436.

https://doi.org/10.1182/blood-2009-10-246561

Published: 2010

Journal Articles

Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Jenna D. Goldberg, MD, Junting Zheng, MA, Juliet Barker, MBBS, Farid Boulad, MD, H.R. Castro-Malaspina, MD, Katharine C Hsu, MD, PhD, Ann Jakubowski, MD, PhD, Nancy Kernan, MD, Richard J O'Reilly,, MD, Esperanza Papadopoulos, MD, Susan Prockop, MD, Andromachi Scaradavou, MD, Marcel van den Brink, MD, PhD, James Young, MD, Glenn Heller, PhD, Miguel-Angel Perales, MD

Blood (2009) 114 (22): 2222.

https://doi.org/10.1182/blood.V114.22.2222.2222

Published: 2009

Journal Articles

IL-17 contributes to CD4-mediated graft-versus-host disease

Lucy W. Kappel, Gabrielle L. Goldberg, Christopher G. King, David Y. Suh, Odette M. Smith, Cassandra Ligh, Amanda M. Holland, Jeremy Grubin, Nicholas M. Mark, Chen Liu, Yoichiro Iwakura, Glenn Heller, Marcel R. M. van den Brink

Blood (2009) 113 (4): 945–952.

https://doi.org/10.1182/blood-2008-08-172155

Published: 2009

Journal Articles

Human Langerhans-Type Dendritic Cells Break Tolerance against the Tumor Antigen, WT1, by a Largely IL-15-Dependent Mechanism.

Emanuela Romano, MD, Rosa Barreira da Silva, BS, Sharanya Chandrasekar, MS, Christian Münz, PhD, Glenn Heller, PhD, James W. Young, MD

Blood (2008) 112 (11): 1554.

https://doi.org/10.1182/blood.V112.11.1554.1554

Published: 2008

NARROW

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

Selection of Unrelated Allogeneic Hematopoietic Cell Donors Based on KIR3DL1 Allotypes Is Feasible and Results in Improved Disease-Free Survival in Transplant Recipients with MDS and AML

Safe mobilization of CD34 + cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation

Janus Kinase-2 Inhibition Induces Durable Tolerance to Alloantigen by Dendritic Cell-Stimulated Human T Cells, Yet Preserves Immunity to Recall Antigen

T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation with Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients with Relapsed Multiple Myeloma and High-Risk Cytogenetics

Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell–stimulated T cells yet preserves immunity to recall antigen

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts

Recombinant Human Interleukin-7 (CYT107) Enhances CD4 and CD8 T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant In Patients with Myeloid Malignancies

Abrogation of Donor T Cell IL-21 Signaling Leads to Tissue-Specific Modulation of Immunity and Separation of Gvhd From GVL

A Novel Reduced Intensity Conditioning Can Induce a High Incidence of Sustained Donor Engraftment After Double Unit Cord Blood Transplantation (CBT) without Anti-Thymocyte Globulin

An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment

Response: Sample size and statistical comparisons of GVHD rates in pediatric Niemann-Pick disease patients

Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

IL-17 contributes to CD4-mediated graft-versus-host disease

Human Langerhans-Type Dendritic Cells Break Tolerance against the Tumor Antigen, WT1, by a Largely IL-15-Dependent Mechanism.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only